Results 141 to 150 of about 2,722 (180)
Some of the next articles are maybe not open access.

Musculoskeletal MRI findings of juvenile localized scleroderma

Pediatric Radiology, 2017
Juvenile localized scleroderma comprises a group of autoimmune conditions often characterized clinically by an area of skin hardening. In addition to superficial changes in the skin and subcutaneous tissues, juvenile localized scleroderma may involve the deep soft tissues, bones and joints, possibly resulting in functional impairment and pain in ...
Eric P, Eutsler   +4 more
openaire   +4 more sources

DNA methylation patterns in juvenile systemic sclerosis and localized scleroderma

Clinical Immunology, 2021
Scleroderma refers to a group of chronic fibrotic immune-mediated diseases of unknown etiology. Characterizing epigenetic changes in childhood-onset scleroderma, systemic sclerosis or localized scleroderma, has not been previously performed. The aim of this study was to assess DNA methylation differences and similarities between juvenile systemic ...
Patrick, Coit   +4 more
openaire   +4 more sources

New Developments in Juvenile Systemic and Localized Scleroderma

Rheumatic Disease Clinics of North America, 2013
Juvenile localized scleroderma (jLS) and juvenile systemic sclerosis (jSS) are both orphan diseases, with jLS around 10 times more frequent than jSS. In recent years the time gap between the appearance of symptoms and diagnosis has become significantly shorter.
Ivan Foeldvari
openaire   +4 more sources

Challenges and complications in juvenile localized scleroderma: A practical approach

Best Practice & Research Clinical Rheumatology
Juvenile localized scleroderma is characterised by inflammation which drives fibrosis in skin and soft tissues. The more severe subtypes of localized scleroderma such as linear and craniofacial are more common in children. Additionally, extracutaneous involvement is seen in half of all children and is associated with poorer treatment outcomes and ...
Clare E. Pain, Kathryn S. Torok
openaire   +4 more sources

Systemic therapy in juvenile localized scleroderma

Expert Review of Clinical Immunology, 2023
Juvenile localized scleroderma (JLS) is a rare sclerosing disorder of childhood which can result in permanent morbidity and functional disability, if not effectively treated. Treatment should be started in the inflammatory phase before the development of any complication and/or damage.In this review, we will discuss how to assess disease activity and ...
Ivan Foeldvari, Edoardo Marrani
openaire   +2 more sources

Predictors of family impact of juvenile localized scleroderma

Pediatric Dermatology, 2021
AbstractObjectiveTo measure the impact juvenile localized scleroderma (jLS) has on family quality of life and to identify predictors of family impact in this population which may inform the development of tailored resources to enhance family functioning for patients with jLS.MethodsA retrospective cohort study of pediatric patients with jLS and their ...
Katia Milovanova   +5 more
openaire   +2 more sources

Juvenile localized scleroderma: A single‐centre experience from India

Journal of the European Academy of Dermatology and Venereology, 2022
AbstractBackgroundJuvenile localized scleroderma (JLS) or morphoea, a rare chronic autoimmune disease predominantly affects skin, subcutaneous tissue and occasionally the adjacent muscle, fascia and bone. We report the largest single‐centre cohort of patients with JLS from India.MethodsPatients who were diagnosed to have JLS were enrolled from the ...
Ankur Kumar Jindal   +11 more
openaire   +2 more sources

BILATERAL CHOROIDAL EXCAVATION IN JUVENILE LOCALIZED SCLERODERMA

RETINAL Cases & Brief Reports, 2018
Purpose: To describe a case of bilateral choroidal excavation in a patient with juvenile localized scleroderma. Methods: Case report. Results: An asymptomatic 12-year-old boy with localized scleroderma presented for examination and was ...
Mackenzie L, Franklin, Shelley, Day
openaire   +2 more sources

Overview of Juvenile localized scleroderma and its management

World Journal of Pediatrics, 2019
Juvenile localized scleroderma (JLS) is a rare pediatric disease characterized by inflammation and skin thickening. JLS is associated with deep tissue and extracutaneous involvement that often results in functional impairment and growth disturbances.
Suzanne C. Li, Rong-Jun Zheng
openaire   +2 more sources

Juvenile localized scleroderma: Is it a benign disease?

Revista Colombiana de Reumatología (English Edition), 2017
Abstract Introduction Juvenile localized scleroderma is a polymorphic disease. It is more prevalent in girls and has a significant morbidity. Extra-cutaneous involvement is common, and polyautoimmunity can reach 7%. The clinical characteristics of this disease in Colombian patients are currently unknown.
Christine Arango   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy